The A.I. Advantage Show™ Evolvepreneur® AIS002:055 [Saurabh Jain] Trialkey's World First Clinical Trial Simulator
Welcome to the Evolvepreneur A.I. Advantage Show
Join me, Richard Wray, to gain the A.I. Advantage today where we dive deep into the transformative power of A.I. to help fast-track your business.
My very special guest today is Saurabh Jain ...
Saurabh Jain is the executive chair of Opyl, a company developing an AI-powered clinical trial design simulator. Opyl has analyzed over 360,000 clinical trials to build models that can predict with 90% accuracy whether a trial will succeed. The key is analyzing hundreds of variables related to trial design and the medical technology, rather than just the drug itself. This allows Opyl to optimize factors like patient numbers to improve the chances of success. Saurabh believes this technology could eventually make it unethical to run clinical trials without first simulating them in AI, drastically improving the efficiency and success rate of drug development. He sees broader applications for AI in automating and optimizing complex processes across many industries.
Key Moments:
- Opyl has developed an AI system that can predict with 90% accuracy whether a clinical drug trial will succeed or fail, based on analyzing over 360,000 past trial records.
- The AI model looks at over 700 variables related to how the trial is structured and the medical details of the drug/treatment being tested to make these predictions.
- Opyl's system can help optimize clinical trial design, such as determining the ideal number of patients to enroll to maximize the chances of success.
- The medical industry has been skeptical at first about an AI being able to predict trial outcomes, but when shown real-world examples, they recognize the value of the technology.
- Opyl believes that in the future, it will be unethical to run clinical trials on humans without first simulating them in an AI system like theirs.
- Beyond healthcare, the guest discusses how similar AI approaches can be applied to optimize outcomes in areas like sports, SEO, and tax compliance.
- There is a concern about AI leading to a "post-knowledge age" where certain skills and knowledge become obsolete, but the guest argues that specialization and AI can free up humans to focus on higher-level tasks.
- The key advice is to embrace AI as a transformative technology that will change everything, and to find ways to leverage it to one's advantage.
- The guest, Saurabh Jain, is the Executive Chair of Opyl, a publicly listed company at the forefront of AI-powered assistive technologies for healthcare.
- Saurabh sees AI as a foundational technology that will be as impactful as electricity or mass transportation, and encourages entrepreneurs to get on board.
Welcome to the Evolvepreneur AI Advantage Show, the ultimate destination for entrepreneurs seeking to harness the full potential of Artificial Intelligence.
Join us on this captivating journey as we delve into the realm where innovation meets intelligence.
In each episode, we dive deep into the transformative power of AI, unveiling the strategies, insights, and tools that propel businesses forward. From deciphering AI algorithms to unlocking data-driven decision-making, our show equips you with the knowledge and skills to leverage AI as a game-changing force.
Engage with industry experts, thought leaders, and fellow entrepreneurs as we explore real-world applications, share success stories, and decode the latest AI trends. Whether you're a seasoned business owner or an aspiring entrepreneur, the Evolvepreneur AI Advantage Show empowers you to embrace the future, optimize operations, and unlock your business's growth potential.
Get ready to revolutionize your entrepreneurial journey with the AI Advantage. Tune in and join the Evolvepreneur community today!
GRAB YOUR A.I. Advantage Free Toolkit when you SUBSCRIBE HERE: https://aiadvantage.show